Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells

Fertility and Sterility
A AriciD L Olive

Abstract

To investigate monocyte chemotactic protein-1 concentrations in the peritoneal fluid (PF) of women with or without endometriosis, then assess peritoneal mesothelial cells as a potential source of monocyte chemotactic protein-1. Prospective study. University medical center. Women with (n = 60) or without (n = 18) endometriosis. First monocyte chemotactic protein-1 levels in PF were measured, then mesothelial cells in culture were treated with cytokines. In PF and culture supernatants, monocyte chemotactic protein-1 was measured by ELISA. In vitro monocyte chemotactic protein-1 messenger RNA expression was evaluated by Northern analysis. The median concentration of monocyte chemotactic protein-1 in PF of control women was 137 pg/mL (conversion factor to SI unit, 0.115; range, 12 to 418 pg/mL); that of women with moderate endometriosis was 205 pg/mL (range 65 to 6,000 pg/mL); and that of those with severe endometriosis was 1,165 pg/mL (0 to 2,602 pg/mL). Within the moderate to severe endometriosis group, monocyte chemotactic protein-1 levels were higher in women with untreated endometriosis (354 pg/mL range 0 to 6,000 pg/mL) than in women receiving GnRH agonist (128 pg/mL, range 0 to 216 pg/mL). In the control group, monocyte chem...Continue Reading

References

Sep 1, 1970·Obstetrics and Gynecology·E P Peterson, S J Behrman
Jul 1, 1995·American Journal of Obstetrics and Gynecology·T M D'HoogheP R Koninckx
Feb 1, 1995·Molecular and Cellular Endocrinology·A AriciM L Casey
Oct 1, 1994·Kidney International·A DouvdevaniC Chaimovitz
Feb 1, 1993·American Journal of Obstetrics and Gynecology·M C LeivaC R Lyttle
Apr 1, 1993·American Journal of Obstetrics and Gynecology·M G HammondJ Halme
Aug 1, 1996·Seminars in Reproductive Endocrinology·E Oral, A Arici
Oct 1, 1962·The Journal of Obstetrics and Gynaecology of the British Empire·S W WRIGHT

❮ Previous
Next ❯

Citations

Jul 10, 2004·Archives of Gynecology and Obstetrics·Ioannis M MatalliotakisEugenios E Koumantakis
Mar 25, 2010·Archives of Gynecology and Obstetrics·Ebru ZulfikarogluSertac Batioglu
Jun 15, 2010·Archives of Gynecology and Obstetrics·Gazi YildirimNarter Yesildaglar
Dec 29, 2012·Journal of Assisted Reproduction and Genetics·Alisa Komsky-ElbazIdo Ben-Ami
Jan 22, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Mohamed A Bedaiwy, Tommaso Falcone
May 17, 2005·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Grzegorz B GmyrekAnna Chelmonska-Soyta
Jul 5, 2001·Fertility and Sterility·T HaradaN Terakawa
Mar 7, 2003·Fertility and Sterility·Mingqing SongSampath Parthasarathy
Oct 15, 2003·Fertility and Sterility·Aydin AriciNeal G Mahutte
Jun 9, 1999·Fertility and Sterility·J A García-Velasco, A Arici
Jul 7, 1999·Journal of Reproductive Immunology·L M Senturk, A Arici
Apr 20, 2001·European Journal of Obstetrics, Gynecology, and Reproductive Biology·D VinatierP Dufour
Nov 27, 2002·Medical Hypotheses·D W Bullimore
Oct 26, 2010·Nutrition Research Reviews·Francesco SestiEmilio Piccione
Jun 17, 2008·Human Reproduction·T OrnekA Arici
Mar 30, 2013·Human Reproduction Update·Fernando M ReisRobert N Taylor
Feb 29, 2000·Molecular Human Reproduction·D I LebovicR N Taylor
Nov 18, 1998·Current Opinion in Obstetrics & Gynecology·D P Braun, W P Dmowski
Aug 19, 1999·Clinical Obstetrics and Gynecology·C A Witz
May 4, 2010·Clinical Obstetrics and Gynecology·Breton F Barrier
Apr 13, 2002·Annals of the New York Academy of Sciences·Nalini SantanamSampath Parthasarathy
Jan 24, 2012·Reproductive Sciences·Hakan CakmakAydin Arici
Jul 12, 2013·Obstetrics and Gynecology International·Antonio Simone LaganàOnofrio Triolo
May 11, 2011·Reproduction : the Official Journal of the Society for the Study of Fertility·Linsay J MacdonaldHenry N Jabbour
Nov 30, 2013·Human Reproduction·G M BorrelliS Mechsner
Oct 2, 2009·Reproduction : the Official Journal of the Society for the Study of Fertility·Henry N JabbourJane E Norman
Apr 14, 2009·Archives of Gynecology and Obstetrics·Caio Parente BarbosaGeraldo Rodrigues de Lima
Nov 6, 2015·International Journal of Molecular Sciences·Min-Kyung JangMyeong Ho Jung
Sep 1, 2015·Women's Health·Rukset Attar, Erkut Attar
Oct 20, 2009·Journal of Minimally Invasive Gynecology·Fred M Howard
Aug 21, 2007·Fertility and Sterility·Beata SeeberKurt T Barnhart
May 30, 2015·Scientific Reports·Bo XuYu-sheng Liu
Jul 17, 2007·American Journal of Reproductive Immunology : AJRI·Osmond J D'Cruz, Fatih M Uckun
Aug 8, 2015·BioMed Research International·Soo Hyun AhnChandrakant Tayade
Jun 1, 1997·Obstetrics and Gynecology Clinics of North America·M Guarnaccia, D L Olive
Sep 26, 2003·American Journal of Reproductive Immunology : AJRI·Murat Berkkanoglu, Aydin Arici
May 27, 2003·American Journal of Reproductive Immunology : AJRI·Aydin AriciNeal G Mahutte
Jul 31, 2013·Proteomics. Clinical Applications·A B SivaSisinthy Shivaji
Jul 1, 2008·Expert Opinion on Medical Diagnostics·Essam El-Din R OthmanAyman Al-Hendy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.